Search Results - "Yee, L. K"

Refine Results
  1. 1

    A phase I II study of imatinib plus reinduction therapy for c-kit-positive relapsed refractory acute myeloid leukemia: inhibition of Akt activation correlates with complete response by Brandwein, J M, Hedley, D W, Chow, S, Schimmer, A D, Yee, K W L, Schuh, A C, Gupta, V, Xu, W, Kamel-Reid, S, Minden, M D

    Published in Leukemia (01-06-2011)
    “…This phase I/II study evaluated imatinib as a c-kit inhibitor combined with mitoxantrone, etoposide and cytarabine therapy for patients with primary refractory…”
    Get full text
    Journal Article
  2. 2

    A phase I study of tipifarnib combined with conventional induction and consolidation therapy for previously untreated patients with acute myeloid leukemia aged 60 years and over by Brandwein, J M, Leber, B F, Howson-Jan, K, Schimmer, A D, Schuh, A C, Gupta, V, Yee, K W L, Wright, J, Moore, M, MacAlpine, K, Minden, M D

    Published in Leukemia (01-04-2009)
    “…Patients aged 60 years and over with previously untreated acute myeloid leukemia were enrolled in a Phase I study combining tipifarnib with standard induction…”
    Get full text
    Journal Article
  3. 3

    Venous thromboembolism prevention during asparaginase-based therapy for acute lymphoblastic leukemia by Sibai, H, Seki, J T, Wang, T Q, Sakurai, N, Atenafu, E G, Yee, K W L, Schuh, A C, Gupta, V, Minden, M D, Schimmer, A D, Brandwein, J M

    Published in Current oncology (Toronto) (01-08-2016)
    “…Venous thromboembolism (vte) is a recognized complication in patients treated with asparaginase-containing chemotherapy regimens; the optimal preventive…”
    Get full text
    Journal Article
  4. 4

    Transrepression activity of T-box1 in a gene regulation network in mouse cells by Yee, Karen K.L., Yagi, Hisato, Matsuoka, Rumiko, Nakanishi, Toshio, Furukawa, Toru

    Published in Gene (01-12-2012)
    “…T-box1 (TBX1) has been identified as a candidate disease-causing gene in DiGeorge syndrome/conotruncal anomaly face syndrome (DGS/CAFS). Tbx1 can function as a…”
    Get full text
    Journal Article
  5. 5

    Integrin-mediated signalling through the MAP-kinase pathway by Yee, K L, Weaver, V M, Hammer, D A

    Published in IET systems biology (01-01-2008)
    “…The mitogen activated protein (MAP) kinase cascade, leading to extracellular-regulated kinase (ERK) activation, is a key regulator of cell growth and…”
    Get full text
    Journal Article
  6. 6

    Improving the efficiency of discrete time scheduling formulation by Yee, K.L., Shah, N.

    Published in Computers & chemical engineering (01-01-1998)
    “…The problem of production scheduling in multipurpose plants can be formulated as a mixed integer linear programming (MILP) problem based on a discrete…”
    Get full text
    Journal Article Conference Proceeding
  7. 7

    High Inter- and Intrapatient Variation in 5-Fluorouracil Plasma Concentrations during a Prolonged Drug Infusion by TAKIMOTO, C. H, YEE, L. K, VENZON, D. J, SCHULER, B, GROLLMAN, F, CHABUK, C, HAMILTON, J. M, CHEN, A. P, ALLEGRA, C. J, GREM, J. L

    Published in Clinical cancer research (01-06-1999)
    “…The purpose of the study was to examine inter- and intrapatient variation in 5-fluorouracil (5-FU) plasma concentrations in adult cancer patients receiving a…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Scheduling of Multistage Fast-Moving Consumer Goods Plants by Yee, K. L., Shah, N.

    “…Fast-moving consumer goods (FMCG) plants are required to be highly flexible due to their multiproduct nature and frequent portfolio changes with seasons or…”
    Get full text
    Journal Article
  10. 10

    Inter- and intraindividual variation in dihydropyrimidine dehydrogenase activity in peripheral blood mononuclear cells by GREM, J. L, YEE, L. K, VENZON, D. J, TAKIMOTO, C. H, ALLEGRA, C. J

    “…The activity of dihydropyrimidine dehydrogenase (DPD), the rate-limiting enzyme in fluorouracil catabolism, has been reported to vary according to time of day…”
    Get full text
    Journal Article
  11. 11

    Metabolism and RNA incorporation of cyclopentenyl cytosine in human colorectal cancer cells by Yee, L K, Allegra, C J, Trepel, J B, Grem, J L

    Published in Biochemical pharmacology (01-04-1992)
    “…We studied the cytotoxicity and metabolism of the investigational cytidine analogue cyclopentenyl cytosine (CPE-C) in three human colorectal cancer cell lines:…”
    Get more information
    Journal Article
  12. 12

    The prognostic impact of FLT3-ITD and NPM1 mutations in patients with relapsed acute myeloid leukemia and intermediate-risk cytogenetics by How, J, Sykes, J, Minden, M D, Gupta, V, Yee, K W L, Schimmer, A D, Schuh, A C, Kamel-Reid, S, Brandwein, J M

    Published in Blood cancer journal (New York) (01-05-2013)
    “…Internal tandem duplication of the fms-like tyrosine kinase-3 gene ( FLT3- ITD) and nucleophosmin-1 ( NPM1 ) mutations have prognostic importance in acute…”
    Get full text
    Journal Article
  13. 13

    Scheduling of multistage fast-moving consumer goods plants by Yee, K L, Shah, N

    “…Fast-moving consumer goods (FMCG) plants are required to be highly flexible due to their multiproduct nature and frequent portfolio changes with seasons or…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17

    Decreased catabolism of fluorouracil in peripheral blood mononuclear cells during combination therapy with fluorouracil, leucovorin, and interferon alpha-2a by Yee, L K, Allegra, C J, Steinberg, S M, Grem, J L

    “…We previously reported that recombinant interferon alpha-2a (IFN alpha-2a) therapy was associated with a dose-dependent decrease in fluorouracil (5-FU)…”
    Get more information
    Journal Article
  18. 18

    Drug–Drug Interaction Studies: Regulatory Guidance and An Industry Perspective by Prueksaritanont, Thomayant, Chu, Xiaoyan, Gibson, Christopher, Cui, Donghui, Yee, Ka Lai, Ballard, Jeanine, Cabalu, Tamara, Hochman, Jerome

    Published in The AAPS journal (01-07-2013)
    “…Recently, the US Food and Drug Administration and European Medicines Agency have issued new guidance for industry on drug interaction studies, which outline…”
    Get full text
    Journal Article
  19. 19

    Genetic variability in Macadamia by Aradhya, M.K. (Hawaii Univ., Honolulu, HI (USA). Dept. of Horticulture), Yee, L.K, Zee, F.T, Manshardt, R.M

    Published in Genetic resources and crop evolution (01-02-1998)
    “…A genetic variability analysis involving 45 accessions of Macadamia including four species, M. integrifolia, M. tetraphylla, M. ternifolia, and M. hildebrandii…”
    Get full text
    Journal Article
  20. 20

    Population Pharmacokinetics and Pharmacodynamics of Bezlotoxumab in Adults with Primary and Recurrent Clostridium difficile Infection by Yee, Ka Lai, Kleijn, Huub Jan, Kerbusch, Thomas, Matthews, Randolph P, Dorr, Mary Beth, Garey, Kevin W, Wrishko, Rebecca E

    Published in Antimicrobial agents and chemotherapy (01-02-2019)
    “…The fully human monoclonal antibody bezlotoxumab is indicated for preventing the recurrence of (formerly ) infection (CDI) in adults who receive antibacterial…”
    Get full text
    Journal Article